Table 1.
Baseline patient characteristics
Characteristics | N = 31 |
---|---|
Age | |
Median age (Range) | 57 (36–75) |
Gender, n (%) | |
Male | 17 (55%) |
Female | 14 (45%) |
ECOG PS | |
0 | 12 (39%) |
1 | 19 (61%) |
Patients receiving concurrent octreotide | 12 (39%) |
Primary disease site | |
Lung—bronchial | 4 (13%) |
Larynx | 1 (3%) |
Stomach | 1 (3%) |
Small bowel | 17 (55%) |
Colon | 2 (6%) |
Rectum | 2 (6%) |
Other/Unknown | 4 (13%) |
Prior cancer treatments | |
Radiation | 7 (23%) |
Cytotoxic chemotherapy | 14 (45%) |
Alpha interferon | 3 (10%) |
Other | 15 (48%) |